UG1HD107696
Cooperative Agreement
Overview
Grant Description
Laaz-NPH Clinical Center - Project Summary
Nutrition is at the epicenter of human health and disease. However, our current "one size fits all" approach to clinical nutrition is failing a large segment of the population. Individual factors including genetics, metabolism, physiology, microbiome, behavior, and the built-in and contextual environment all underlie the inherent variability in response to diets.
Exciting new research shows that machine learning algorithms can integrate this complex information and predict how someone responds to a given diet. If validated, this innovative approach will provide a radical change in the delivery of personalized nutrition prescriptions to promote health and treat chronic diseases.
The goal of the "Nutrition for Precision Health (NPH), powered by All of Us" consortium is to generate a rich database from a diverse population to develop a first-of-its-kind diet prediction algorithm. The aim of the Louisiana-Arizona Nutrition for Precision Health Center (Laaz-NPH), consisting of LSU-Pennington Biomedical (PBRC) in Baton Rouge, LSU-Health Sciences Center (LSUHSC) in New Orleans, and the NIDDK-Phoenix Clinical Center (PIMC) in Phoenix, is to participate in the NPH consortium as a clinical center to recruit, enroll, and retain more than 2000 participants in the three planned study modules.
In Module 1, 2000 participants from the All of Us research program in Louisiana (Baton Rouge and New Orleans; 600 each) and Arizona (Phoenix; 800) will be enrolled in a 10-day prospective, observational study. Following the completion of Module 1, 300 study participants who meet specified eligibility criteria for enrollment in the controlled feeding studies will participate in Module 2 (PBRC, LSUHSC, and PIMC; 100 each) and at least 100 in Module 3 (PBRC and PIMC only; =50 each).
Module 2 is a controlled feeding study in an outpatient setting with 300 study participants, while Module 3 is a controlled feeding study in an inpatient setting with at least 100 study participants that completed Module 1. Modules 2 and 3 will use a block randomization crossover study design to evaluate the individual response to three 14-day isocaloric diet interventions. The three intervention diets (a combination of the Mediterranean and DASH diet (MEDASH); a sustainable predominantly plant-based flexitarian diet (FLEX); and a highly preferred Western diet (HPWD)) will be separated by 7-21 day washout periods.
Our primary endpoint is the post-prandial plasma glucose response (PPGR) to a standardized mixed meal tolerance test (MMTT) as measured by the incremental glucose area under the curve over 180 minutes (AUC180). Secondary endpoints are biomarkers of cardiometabolic health including insulin resistance and a metabolic syndrome score.
The rich set of data and biospecimens collected by our proposed center will be used to inform paradigm-shifting approaches that enable large-scale delivery of personalized dietary prescriptions to promote general health, delay cardiometabolic diseases, and importantly address health disparities.
Nutrition is at the epicenter of human health and disease. However, our current "one size fits all" approach to clinical nutrition is failing a large segment of the population. Individual factors including genetics, metabolism, physiology, microbiome, behavior, and the built-in and contextual environment all underlie the inherent variability in response to diets.
Exciting new research shows that machine learning algorithms can integrate this complex information and predict how someone responds to a given diet. If validated, this innovative approach will provide a radical change in the delivery of personalized nutrition prescriptions to promote health and treat chronic diseases.
The goal of the "Nutrition for Precision Health (NPH), powered by All of Us" consortium is to generate a rich database from a diverse population to develop a first-of-its-kind diet prediction algorithm. The aim of the Louisiana-Arizona Nutrition for Precision Health Center (Laaz-NPH), consisting of LSU-Pennington Biomedical (PBRC) in Baton Rouge, LSU-Health Sciences Center (LSUHSC) in New Orleans, and the NIDDK-Phoenix Clinical Center (PIMC) in Phoenix, is to participate in the NPH consortium as a clinical center to recruit, enroll, and retain more than 2000 participants in the three planned study modules.
In Module 1, 2000 participants from the All of Us research program in Louisiana (Baton Rouge and New Orleans; 600 each) and Arizona (Phoenix; 800) will be enrolled in a 10-day prospective, observational study. Following the completion of Module 1, 300 study participants who meet specified eligibility criteria for enrollment in the controlled feeding studies will participate in Module 2 (PBRC, LSUHSC, and PIMC; 100 each) and at least 100 in Module 3 (PBRC and PIMC only; =50 each).
Module 2 is a controlled feeding study in an outpatient setting with 300 study participants, while Module 3 is a controlled feeding study in an inpatient setting with at least 100 study participants that completed Module 1. Modules 2 and 3 will use a block randomization crossover study design to evaluate the individual response to three 14-day isocaloric diet interventions. The three intervention diets (a combination of the Mediterranean and DASH diet (MEDASH); a sustainable predominantly plant-based flexitarian diet (FLEX); and a highly preferred Western diet (HPWD)) will be separated by 7-21 day washout periods.
Our primary endpoint is the post-prandial plasma glucose response (PPGR) to a standardized mixed meal tolerance test (MMTT) as measured by the incremental glucose area under the curve over 180 minutes (AUC180). Secondary endpoints are biomarkers of cardiometabolic health including insulin resistance and a metabolic syndrome score.
The rich set of data and biospecimens collected by our proposed center will be used to inform paradigm-shifting approaches that enable large-scale delivery of personalized dietary prescriptions to promote general health, delay cardiometabolic diseases, and importantly address health disparities.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Place of Performance
Baton Rouge,
Louisiana
708084124
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 491% from $1,242,018 to $7,341,823.
Pennington Biomedical Research Center was awarded
LAAZ-NPH Clinical Center
Cooperative Agreement UG1HD107696
worth $7,341,823
from the National Institute of Allergy and Infectious Diseases in December 2021 with work to be completed primarily in Baton Rouge Louisiana United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.310 Trans-NIH Research Support.
The Cooperative Agreement was awarded through grant opportunity Nutrition for Precision Health, powered by the All of Us Research Program: Clinical Centers (UG1 Clinical Trial Required).
Status
(Ongoing)
Last Modified 12/20/24
Period of Performance
12/10/21
Start Date
11/30/26
End Date
Funding Split
$7.3M
Federal Obligation
$0.0
Non-Federal Obligation
$7.3M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for UG1HD107696
Transaction History
Modifications to UG1HD107696
Additional Detail
Award ID FAIN
UG1HD107696
SAI Number
UG1HD107696-661093888
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NT00 NIH EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
MWYVQTQ32ME5
Awardee CAGE
47W83
Performance District
LA-06
Senators
Bill Cassidy
John Kennedy
John Kennedy
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Office of the Director, National Institutes of Health, Health and Human Services (075-0846) | Health research and training | Grants, subsidies, and contributions (41.0) | $2,806,177 | 100% |
Modified: 12/20/24